期刊文献+

血清同型半胱氨酸、成纤维细胞生长因子23、klotho蛋白与血液透析患者心血管功能关系研究 被引量:8

Study on relationship between Hcy,FGF 23,klotho and cardiovascular disease in hemodialysis patients
下载PDF
导出
摘要 目的探讨血清同型半胱氨酸(Hcy)、成纤维细胞生长因子23(FGF-23)、klotho蛋白与血液透析患者心血管疾病的关系。方法选取2014年6月-2015年5月在本院进行维持性血液透析患者共85例为研究组,同时选择进行体检的85名健康人为对照组。研究组又分为心血管功能差组(n=29)与心血管功能正常组(n=56)。所有研究对象检测采血检测空腹血糖(FPG)、血红蛋白(Hb)、白蛋白(ALB)、肌酐(Cr)、尿素氮(BUN)、尿酸(UA)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL)、低密度脂蛋白胆固醇(LDL)、FGF-23、Hcy和klotho蛋白水平,并比较分析。结果研究组血清ALB、Hb、HDL和Klotho蛋白含量的水平低于对照组,Cr、BUN、UA、FGF23和Hcy水平高于对照组,差异均有显著性(P<0.05),两组的FPG、TC、TG和LDL的含量无显著差异(P>0.05)。心血管功能差组的FGF23、Hcy含量显著高于心血管功能正常组,Klotho蛋白显著低于心血管功能正常组。结论 Hcy、FGF 23和klotho蛋白与维持性血液透析患者心血管病变有着密切的联系。 Objective To investigate the relationship between Hcy,FGF23,klotho and cardiovascular disease in hemodialysis patients. Methods 85 patients with maintenance hemodialysis in our hospital from June 2014 to May 2015 were selected as study group, and 85 healthy personnel at the same time were selected as control group. The study group was divided into cardiovascular disease group(n = 29) and non-cardiovascular disease group (n= 56). Serum levels of fasting plasma glucose(FPG), blood hemoglobin(Hb), alburnin(ALB), creatinine(Cr), blood urea nitrogen(BUN), uric acid ( UA), triglycerides ( TG), total cholesterol ( TC), high density lipoprotein cholesterol ( HDL), low density lipoprotein cholesterol(LDL),.FGF-23,Hcy and klotho were detected in all of the subjects, and comparative analysis was undertaken. Results Serum levels of Cr, BUN, UA, FGF23 and Hcy were significantly higher than the control group (all P〈0.05);FPG, Hb,ALB, HDL and klotho in the study group were significantly lower than the control group; FPG.TC.TG and LDL had no significant differences in two groups(all P〉0.05). FGF23 and Hcy in cardiovascular disease group was significantly higher than non cardiovascular disease group, and Klotho was significantly lower than non-cardiovascular disease group. Conclusion Hcy,FGF 23 and klotho are closely linked to cardiovascular disease in patients with maintenance hemodialysis.
作者 李春明
出处 《中国实验诊断学》 2015年第11期1856-1859,共4页 Chinese Journal of Laboratory Diagnosis
关键词 血液透析 血清同型半胱氨酸 成纤维细胞生长因子23 KLOTHO蛋白 心血管功能 Hemodialysis Hcy FGF-23 Klotho Cardiovascular disease
  • 相关文献

参考文献7

  • 1孙颖,陈爱群,王川予,李超群,毛永辉,吴华.血液透析患者颈动脉内中膜厚度与血清高敏C反应蛋白、成纤维细胞生长因子23和klotho蛋白的相关性研究[J].中国血液净化,2014,13(1):17-22. 被引量:13
  • 2Fedak D,Bigaj K, Suowicz W. Fibroblast growth factor-23 (FGF- 23). Part III. Relationship between FGF-23 serum concentration and cardio-vascular morbidity and mortality[J]. Przegl Lek, 2011, 68(9) : 614.
  • 3Smith K, deFilippi C, Isakova T, et al. Fibroblast growth factor 23, high sensitivity cardiac troponin, and left ventricular hypertro- phy in CKD[J]. Am J Kidney Dis,2013,61(1) :67.
  • 4杨松涛,覃莲香,胡军,肖跃飞.血液透析患者血浆同型半胱氨酸与心血管疾病的关系[J].中国血液净化,2009,8(12):665-668. 被引量:8
  • 5Unsal A, Kose Budak S, Koc Y, et al. Relationship ot llbroblast growth factor 23 with left ventricle mass index and coronary cal- cificaton in chronic renal disease[J]. Kidney Blood Press Res, 2012,36(1) : 55.
  • 6Ketteler M, Biggar PH, Liangos O. FGF23 antagonism., the thin line between adaptation in chronic kidney disease[J]. Nephrol Dial Transplant, 2013,28 (4) :821.
  • 7Hu MC,Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease[J]. J Am Soc Nephro, 2011,22(1) : 124.

二级参考文献37

  • 1田军,张金元,胡大勇.肾功能损害对血浆同型半胱氨酸浓度的影响[J].中国血液净化,2005,4(10):542-544. 被引量:9
  • 2Centers for disease control and prevention (CDC).Statespecific trends in chronic kidney failure, United States, 1990-2001[J].MMWR Morb Mortal Wkly ReD, 2004, 53: 918-920.
  • 3Locatelli F, Marcelli D, Conte F. Cardiovascular disease in chronic renal failure: The challenge continues[J]. Nephrol Dial Transplant, 2000, 15:69-80.
  • 4Oishi K, Nagake Y, Yamasaki H, et al. The significance of atherogenic indices in patients on hemodialysis [J]. Am J Nephrol, 2000,20:107-115.
  • 5Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinemia: a critical review of old and new aspects[J]. Curt Drug Metab, 2007, 8:17-31.
  • 6Buccianti G, Baragetti I, Bamonti F, et al. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease[J]. J Nephrol, 2004, 17:405-410.
  • 7Guttormsen AB, Ueland PM, Faglia G, et al. Kinetic basis of hyperhomocysteinemia in patient chronic renal failure [J]. Kidney International, 1997, 52:495-502.
  • 8Suliman ME, Stenvinkel P, Heimbu rger O, et al. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy [J]. Am .J Kidney Dis. 2002, 40:480-488.
  • 9Shukla N, Thompson CS, Angelini GD, et al. Homocysteine enhances impairment of endothelium-dependent relaxation and gnanosine cyclic monophosphate formation in aortae from diabetic rabbits[J]. Diabetologia, 2002, 45:1325- 1331.
  • 10Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomoeysteinemia as an adverse cardiovascular risk factor in end-stage renal disease[J]. Circulation, 1998, 97:138? 41.

共引文献19

同被引文献67

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部